Drug Injury

Primary Pulmonary Hypertension

What is Primary Pulmonary Hypertension?
Primary Pulmonary Hypertension (PPH) is a rare, progressive disorder characterized by high blood pressure (hypertension) of the main artery of the lungs (pulmonary artery). The pulmonary artery is a blood vessel carrying oxygen-poor blood from the right ventricle (one of the heart’s pumping chambers) to the lungs. In the lungs, the blood picks up oxygen, then flows to the heart’s left side, where the left ventricle pumps it to the rest of the body through the aorta (1).

The American Heart Association (www.americanheart.org) says, “Hypertension is a medical term for abnormally high blood pressure. This abnormally high pressure (pulmonary hypertension) is linked with changes in the small blood vessels in the lungs. These changes increase resistance to blood flowing through the vessels. This increased resistance puts a strain on the right ventricle, which now must work harder than usual to move enough blood through the lungs.”

PPH Statistics:
In the United States, an estimated 500 to 1,000 new cases of primary pulmonary hypertension are diagnosed each year.

The greatest number is reported in women between ages 20 and 40. However, men and women in all age ranges - as well as very young children - can develop PPH (2).

What are the symptoms of PPH?
The most common symptoms of primary pulmonary hypertension are related to difficulty breathing. They include:

  • Progressive shortness of breath (especially with activity)
  • Hyperventilation (breathing harder and faster)
  • Swelling of ankles or feet (edema)
  • Fatigue (tiring easily)
  • Chest pain (angina)
  • Progressive weakness
  • Fainting spells
  • Lightheadedness or dizziness
  • Coughing up blood
  • Progressive cyanosis (blue tinge to lips, hands and feet)
Later symptoms, provided by the National Heart, Lung, and Blood Institute (www.nhlbi.nih.gov) involve:
  • The pumping action of your heart grows weaker
  • Your energy decreases
In the more advanced stages, you:
  • Are able to perform very little activity
  • Have symptoms even when resting
  • May become completely bedridden
What causes PPH?
PPH is still not totally understood by the medical community; while doctors and physicians are unable to compile a definite list of dangerous drugs or environmental conditions resulting in the development of PPH, a study by the World Health Organization (www.who.int) suggests appetite suppressants such as “fen-phen” and amphetamines have a “very likely causative role in pulmonary hypertension (3).”

According to an article in the American Family Physician (www.aafp.org), “The use of appetite-suppressant drugs for more than three months is associated with a greater than 30 times increased risk of developing pulmonary hypertension. In the United States, the anorexic agents fenfluramine and dexfenfluramine were recalled in September 1997, only 18 months after they were released (4).”

The World Health Organization cited aminorex (the appetite suppressant aminorex fumarate is thought to have caused an epidemic of pulmonary hypertension in Europe in the 1960s), fenfluramine and dexfenfluramine (“fen-phen”) on the ‘risk factors for Primary Pulmonary Hypertension – definite causal relationship’ list at the World Symposium on Primary Pulmonary Hypertension conference.

What if I have been diagnosed with PPH?
Always consult your physician for medical advice. PPH therapy has advanced significantly in recent years, which has resulted in increased survival rates amongst people with this disease. Unfortunately, there is no cure for PPH. If you or someone you care about has been diagnosed with PPH, contact our law firm today for a free and immediate evaluation of your case.

Sources:

Pulmonary Hypertension, Primary, WebMD (www.webmd.com), June 11, 2004.

Primary or Unexplained Pulmonary Hypertension, American Heart Association (www.americanheart.org) accessed June 8, 2005.

Rich S, ed. Executive summary from the World Symposium on Primary Pulmonary Hypertension, 1998, Evian France, September 6-10, 1998, cosponsored by the World Health Organization.

Diagnosis and Treatment of Pulmonary Hypertension, Trenton D. Nauser, M.D. and Steven W. Sittes, M.D. May 1, 2001, Voulme 63, American Family Physician.

This article is for informational purposes only. It is not intended to constitute medical advice and should not be viewed as such. For medical advice, you should always consult with your physician.

This law firm is not affiliated with, sponsored by or associated with WebMD, the American Heart Association, the National Heart, Lung, and Blood Institute, the World Health Organization, or the American Family Physician publication.

Free Consultation

Contact Ferrer, Poirot & Wansbrough Today

Our firm handles cases involving Auto Accidents, Birth Injuries, Drug Injuries, Drug Injuries, Defective Medical Devices, Environmental Dangers, Medical Malpractice Claims, Motorcycle Accidents, Nursing Home Abuse, Nursing Home Neglect, and Truck Accidents.

If you have been seriously injured, contact a personal injury lawyer at Ferrer, Poirot & Wansbrough Law Firm today. We have successfully advocated for clients throughout the country. Complete a FREE Online Consultation Form or call us today.

© 2006 Ferrer, Poirot & Wansbrough Injury Lawyers. All rights reserved.
| Print This Page | Site Map | Empowered by cj Advertising | Disclaimer | Links | Blog

Bookmark our site: Yahoo Bookmark Del.icio.us Bookmark Simpy Bookmark Technorati Bookmark

Hot Topics

  • Asthma Medication Dangers

    May increase the risk of asthma-related death.

  • Avandia®

    Avandia®, or rosiglitazone, is a drug used by millions of Americans to treat diabetes.

  • Baycol®

    Baycol® was prescribed to help lower cholesterol, but it came with the risk of kidney damage or failure.

  • Birth Control Patch

    Women using Ortho Evra are at an increased risk for fatal blood clots.

  • Chantix®

    Linked to depression, suicidal thoughts, and violent behavior in some users.

  • Contaminated Heparin Syringes

    Dangerous bacteria in heparin-filled syringes in several states.

  • Dead Jaw

    Fosamax® (alendronate), has been linked to osteonecrosis of the jaw (ONJ).

  • Defibrillator Recall

    The Food and Drug Administration reported that Guidant Corporation had recalled certain defibrillators.

  • Digitek Heart Drug

    The Food and Drug Administration has issued a Class I recall of the drug Digitek.

  • Heparin Nationwide Recall

    Increased number of adverse reactions to the drug.

  • Hernia Patch Danger

    The Bard® Composix® Kugel™Mesh Patch is used to repair ventral (incisional) hernias.

  • HRT Injury

    HRT's drug therapy has shown to increase the risks for strokes and more.

  • Medtronic Sprint Dangers

    May break down and deliver life-threatening shocks.

  • MRI Dye (NSF)

    A dye used in MRI & MRA scans has been linked to a rare & potentially fatal skin disease in some users.

  • Pain Patch Recall

    Manufacturing defects that could result in fatal overdoses.

  • Paxil®

    The FDA notified healthcare professionals of changes to the Prescribing Information for Paxil.

  • Permax®

    Permax® has been linked to serious and potentially fatal heart valve damage in some users.

  • Seroquel®

    Seroquel® is pharmaceutical drug in the class of atypical antipsychotics approved by the FDA.

  • Stevens-Johnson Syndrome (SJS)

    Severe skin reactions that include rashes and blisters.

  • Trasylol®

    Results have revealed an increase in mortality of patients who receive Trasylol®.

  • Yamaha Rhino Rollover

    Yamaha Motor Company’s popular “Rhino” ATV may pose serious and life-threatening risks.

2603 Oak Lawn
Suite 300
Dallas, Texas 75219
1-866-535-4820
Personal Injury Lawyer

Practice Areas

Click Here for a Free Consultation

Injured?